"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

Bengt Rasmussen, Gudrun Gohring, Elsa Bernard, Lars Nilsson, Magnus Tobiasson, Martin Jadersten, Hege Garelius, Ingunn Dybedal, Kirsten Gronbaek, Elisabeth Ejerblad, Fryderyk Lorenz, Max Flogegard, Claus Werenberg Marcher, Annette oster Fernstrom, Lucia Cavelier, Elli Papaemmanuil, Freja Ebeling, Astrid Olsnes Kittang, Jan Maxwell Norgaard, Leonie SaftLars Mollgard, Eva Hellstrom-Lindberg*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftLetterpeer review

11 Citationer (Scopus)
19 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftLeukemia
Vol/bind36
Udgave nummer5
Sider (fra-til)1436-1439
Antal sider4
ISSN0887-6924
DOI
StatusUdgivet - maj 2022

Citationsformater